SIBN

SI-BONE, Inc.

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1459839Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$201.0M

Net Income FY2025

$(19.0M)

EPS (Basic, as reported)

$-0.44

Net Margin FY2025

-9.4%

ROE FY2025

-10.6%

Total Equity

$178.0M

Shares Out

45M

Business description

SI-BONE, Inc. — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2017–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 48 → 201 +19.6% CAGR

Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue4855677390106139167201

Cost of revenue(5)(5)(7)(9)(10)(16)(29)(35)(41)

Gross profit435161648091109132160

Research & development(6)(5)(7)(9)(12)(14)(15)(17)(17)

Selling & marketing(42)(44)(68)(74)(94)(108)(110)(117)(124)

General & administrative(13)(13)(21)(20)(25)(29)(31)(34)(41)

Total operating expenses(60)(63)(97)(103)(131)(150)(156)(167)(182)

Operating income(17)(12)(36)(39)(52)(60)(47)(35)(22)

Interest expense(6)(5)(5)(6)(5)(3)(3)(3)(3)

Interest & investment income013101786

Other income (expense), net0(1)0000000

Pre-tax income(23)(17)(38)(44)—————

Income tax expense00——00000

Net income(23)(17)(38)(44)(57)(61)(43)(31)(19)

EPS — basic———($1.50)($1.71)($1.79)($1.13)($0.75)($0.44)

EPS — diluted———($1.50)($1.71)($1.79)($1.13)($0.75)($0.44)

Shares outstanding — basic (M)———293334384143

Shares outstanding — diluted (M)———293334384143

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.